Connect with us

Press Release

First Human Clinical Trials Of A Potentially Game-Changing Broad Spectrum Antiviral Are Progressing Successfully Drug Could Treat COVID, RSV And Many Other Respiratory Viruses

Published

on

–News Direct–

By Rachael Green, Benzinga

As COVID cases begin to rise again, heralding the beginning of another COVID wave, new variants have appeared leading this wave. EG.5 (Eris) is currently in the majority in the U.S.A, but a very different variant, BA.2.86 (Pirola) is already rising in the number of cases. BA.2.86 carries more than 30 changes in its spike protein, as well as changes in other proteins.

Scientists believe it is questionable whether the newest booster vaccine shots would be effective for this one. The newest vaccines are single-agent targeting the XBB variant. It is not known how effective the approved drugs (mainly Paxlovid – Pfizer Inc. (NYSE: PFE)) would be against this new variant, and further on, as the virus keeps changing. It is now clear that the SARS-CoV-2 virus is here to stay, and that it will keep changing as it continues to learn to avoid vaccines and antibodies and our own immune systems and continues to learn to resist existing old-fashioned drugs. Even without new variants, for clinically vulnerable patients COVID has always continued to be a terrifying reality.

In light of this, the broad-spectrum antiviral that is based on a novel nanomedicines platform being developed by one emerging drug company could be promising.

NanoViricides, Inc (NYSE American: NNVC) announced that it has made progress on its Phase 1a/1b clinical trial of NV-CoV-2, a novel antiviral drug candidate that has the potential to treat all strains of the coronavirus. The clinical-stage biotech reported that the safety and tolerability parts of the trial testing the antiviral in healthy subjects is nearly complete and its now preparing for the efficacy and dose optimization part of the trial with COVID patients.

NanoViricides Broad Spectrum Antiviral Could Change How We Treat Viral Infections

So far, NanoViricides has built a robust foundation of promising preclinical research that demonstrates the unique antiviral platforms potential to treat not just COVID-19 but a wide range of other common and hard-to-treat viral diseases like other coronaviruses, RSV, shingles, herpes, rabies and the flu.

The reason it could have such broad applicability is because the NanoViricides platform was specifically designed to target a particular binding site thats common across many viruses and doesnt change even as a virus mutates. Essentially, the nanoviricide platform mimics the binding site on a human cell that a virus would normally target in order to infect that cell. Then it seeks out the virus and when the virus binds to the nanoviricide instead, the drug candidate immediately engulfs the virus, where its unable to infect the patients cells or reproduce.

The First Of These Drugs Is Now In Human Phase 1a And 1b Clinical Trials

The Phase 1a/1b clinical trial includes single-ascending dose (SAD) and multiple-ascending dose (MAD) safety and tolerability studies in healthy subjects. NanoViricides reported that 26 of the 36 volunteers in the SAD study and 17 of the 36 volunteers in the MAD study have already completed the program. And so far, the early data looks promising. Neither adverse events nor serious adverse events have been found to date in either study.

"The excellent safety and tolerability of NV-CoV-2 in both formulations in the clinical trials is consistent with the results of pre-clinical animal studies, giving us confidence that our preclinical animal studies can be expected to be predictive of human clinical trials, said NanoViricides Executive Chairman and President, Anil R. Diwan, Ph.D.

Ongoing Phase 1a And 1b Clinical Trials Will Give First Indication Of Nanoviricides Efficacy In Humans

With that baseline of safety and tolerability, the next part of the trial is to enroll COVID patients in the trial and start evaluating whether the positive preclinical effectiveness results for the drug will translate to human trials. Once this trial is finished, NanoViricides plans to seek permission to move into phase 2 clinical trials from multiple regulatory agencies worldwide.

Of note, the same drug was found to be effective in pre-clinical studies against another important respiratory virus, RSV. Such a broad spectrum antiviral effectiveness is reminiscent of the development of antibiotics against bacteria. This could be a game-changing development in antiviral therapeutics.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.

Contact Details

Benzinga

+1 877-440-9464

[email protected]

Company Website

http://www.benzinga.com

View source version on newsdirect.com: https://newsdirect.com/news/first-human-clinical-trials-of-a-potentially-game-changing-broad-spectrum-antiviral-are-progressing-successfully-drug-could-treat-covid-rsv-and-many-other-respiratory-viruses-451843874

Benzinga

comtex tracking

COMTEX_440516962/2655/2023-09-19T09:24:35

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Ripmex Debuts RPX Tokens PreSale: Commission-Free Trading for a New Financial Era

Published

on

Ripmex Announces PreSale of Commission-Free RPX Tokens – The Native Token of Its Currency Exchange Market

Washington, United States, 20th Jul 2024, King NewsWireRipmex is excited to announce the presale of its innovative real-time gross settlement token, RPX. Designed to transform global currency exchange, RPX facilitates secure, low-cost transactions for banks, payment providers, digital asset exchanges, and businesses. By eliminating commission fees, RPX enhances potential profitability and provides seamless, instant transfers across various networks. The presale offers a unique opportunity for early investors to engage with Ripmex’s cutting-edge technology and be part of a revolutionary financial ecosystem.

What is Ripmex?

Ripmex aims to enable banks, payment providers, digital asset exchanges, and companies to send money and value globally, securely, and with low transaction fees. Utilizing advanced blockchain technology, Ripmex offers a commission-free currency exchange network that allows users to exchange, buy, and sell funds without incurring fees.

Key Features of RPX

Commission-Free Transactions

RPX operates entirely commission-free, allowing investors worldwide to save money and increase their potential profit margins. Whether trading on centralized exchanges (CEX) or decentralized exchanges (DEX), RPX ensures users pay zero commission fees.

Real-Time Gross Settlement

In the crypto industry, RPX will be known as a real-time gross settlement token. This designation underscores its capability to facilitate instantaneous transactions across different networks, providing unmatched efficiency and security in currency exchange.

Staking and Blockchain Development

RPX represents a comprehensive ecosystem. With plans to establish its own blockchain, RPX offers staking opportunities, allowing users to earn rewards while supporting the network’s security and operations.

Advanced AI Technology

Ripmex is also at the forefront of integrating artificial intelligence (AI) to enhance user experience and investment strategies. The upcoming RPX application, powered by AI, will:

Determine Optimal Trading Points: The AI technology will analyze market conditions to provide users with opportunities for buy and sell points for cryptocurrencies.

Assess Presale Projects: The app will evaluate new token projects, distinguishing reliable investments from potential risks, thereby helping users make informed decisions.

Provide Real-Time Insights: With comprehensive data analytics, users can evaluate presale opportunities based on key metrics such as project stage, funding targets, and token economics.

PreSale Details

The RPX presale is now live, offering an opportunity for early investors to acquire tokens at a favorable rate. By participating in the presale, investors can leverage the innovative features of RPX, gain early access to the platform’s benefits, and contribute to the development of a revolutionary financial ecosystem.

Ripmex is set to redefine currency exchange and trading with its innovative RPX token, offering zero commission fees and advanced AI-driven tools.

About Ripmex

RPX technology allows users to trade on CEX and DEX exchanges without paying commission. RPX has an infrastructure where companies and individuals can save money in their commercial lives.

In quick buy and sell transactions, users can convert RPX tokens into cash without paying commission or obtain RPX without paying commission. The RPX chain token, built on agreements with CEX and DEX exchanges, can be used worldwide. Aiming to establish its own blockchain, RPX can be staked.

In the Blockchain technology era, RPX provides convenience to investors with launch panels. RPX has signed a new era in Blockchain with its expert team and various encrypted parameters in the field of Blockchain technology. 

For more information and to participate in the presale, users can visit:

Presale: https://sale.ripmex.com 

Website: https://ripmex.com 

Twitter(X): https://x.com/RipmexOfficial 

Telegram: https://t.me/Ripmex

Contact email: [email protected]

Media Contact

Organization: Ripmex

Contact Person: Tyrone

Website: https://ripmex.com

Email: Send Email

City: Washington

Country: United States

Release Id: 20072414516

The post Ripmex Debuts RPX Tokens PreSale: Commission-Free Trading for a New Financial Era appeared first on King NewsWire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Unlock Ultimate Health with the Nation’s Top Alkaline Diet Series, Flip McGyver’s Alkaline Life Diet

Published

on

United States, 20th Jul 2024, King NewsWireIn the fast-paced world we live in, maintaining optimal health often feels like an uphill battle. But what if the secret to vitality, energy, and longevity was as simple as choosing the right foods? Enter Flip McGyver, the seven-time best-selling, award-winning author behind the transformative “Alkaline Life Diet” series, which is now the #1 selling alkaline diet book in the country! 

Why the Alkaline Life Diet Series is a Game-Changer 

Flip McGyver’s groundbreaking journey into the world of alkaline diets began with his first book, “The Alkaline Life,” published in 2018. This book quickly garnered worldwide acclaim, inspiring a series of follow-up volumes that have captivated readers across the globe. But what makes this series stand out in the crowded field of diet and health books? 

Proven Success: The Alkaline Life Diet series isn’t just popular—it’s the best-selling alkaline diet book in the nation. Thousands of readers have experienced life-changing health benefits, from increased energy levels to significant weight loss and improved overall wellness. 

Comprehensive Approach: Whether you’re reading “The Alkaline Life Diet: Health is Wealth Cookbook Edition” or “The Alkaline Life Silenced By The System: The Dr. Sebi Story,” each book provides a deep dive into the science behind alkaline foods, practical recipes, and actionable advice that make transitioning to an alkaline lifestyle easy and enjoyable. 

Holistic Health: Flip McGyver’s philosophy goes beyond mere dieting. His motto, “It’s not just a diet; it’s a new way of life,” reflects a commitment to holistic health that nurtures the body, mind, and spirit. His books empower readers to make informed choices that lead to lasting health and vitality. 

The Alkaline Life Diet Series – A Reader’s Perspective 

What do readers have to say about the Alkaline Life Diet series? Testimonials pour in from across the country, with readers sharing incredible stories of transformation: 

“I never knew I could feel this good just by changing my diet. Flip’s books are a lifesaver!” – Maria J. 

“The recipes are not only delicious but have also helped me lose 20 pounds and keep it off!” – James T. 

“Flip McGyver’s insights into the healthcare system are eye-opening. This series is a must-read for anyone serious about their health.” – Linda K. 

Take Control of Your Health Today 

Are you ready to join the health revolution? With the Alkaline Life Diet series, you’re not just buying a book; you’re investing in a brighter, healthier future. Flip McGyver’s proven methods and inspiring guidance will help you unlock the secrets to ultimate health and well-being. 

Don’t wait—take the first step towards a healthier, more vibrant life today. Visit TheAlkalineLifeDiet.com or find Flip McGyver’s books on Amazon and other major retailers. Discover why the Alkaline Life Diet series is the #1 choice for health-conscious individuals nationwide. 

Special Offer 

For a limited time, get exclusive access to Flip McGyver’s latest book, “The Alkaline Life Trilogy,” which combines three of his best-selling books into one comprehensive guide. Order now and take advantage of this special offer to kickstart your journey to optimal health. 

Media Contact

Organization: The Alkaline Life Diet

Contact Person: Flip Mcgyver

Website: http://thealkalinelifediet.com/

Email: Send Email

Country: United States

Release Id: 20072414524

The post Unlock Ultimate Health with the Nation’s Top Alkaline Diet Series, Flip McGyver’s Alkaline Life Diet appeared first on King NewsWire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Tektronic in Central Scotland Revives Classic Porsche Engines for Enthusiasts across the UK

Published

on

Tektronic, based in Central Scotland, is making waves in the classic car community by specialising in restoring and rebuilding classic Porsche engines. Serving Porsche enthusiasts from all over the UK, Tektronic has established itself as a premier destination for those looking to preserve the performance and heritage of their beloved vehicles. The company focuses on iconic models such as the Porsche 911, the pioneering 356, and the performance-centric 944, offering expert services that ensure these classics continue to deliver the driving experience they were designed for. Tektronic’s commitment to quality and meticulous attention to detail set them apart in a niche market, providing a valuable alternative to traditional manufacturer services.

The need for specialised restoration services for classic Porsches is significant. Owners of these iconic vehicles often face high costs and limited service options when seeking engine restorations through manufacturers. Independent garages like Tektronic fill a crucial gap in the market by offering cost-effective and reliable alternatives. Tektronic specialises in rebuilding engines with a detailed and efficient process that involves sourcing high-quality, genuine parts and applying advanced restoration techniques. Each project is tailored to the vehicle’s specific needs, ensuring that every component is either restored or replaced to maintain the engine’s performance and reliability. This personalised approach enhances the vehicle’s longevity and preserves its authenticity and value.

One of the major challenges in restoring classic engines is sourcing authentic parts, a task that Tektronic excels at. The company goes to great lengths to find high-quality, genuine parts that are essential for maintaining the integrity of the original engine. This dedication to authenticity ensures that the restored engines are as close to their original condition as possible, preserving the legacy of these classic vehicles. The rebuilding process requires a deep understanding of each component involved, and Tektronic’s team possesses the specialised knowledge necessary to perform these intricate restorations. Their expertise covers a wide range of models, and they employ advanced techniques to ensure that the engines not only perform at their peak but also retain their historical significance.

Tektronic also prioritises client experience, inviting potential customers to visit their workshop in Central Scotland to witness firsthand the professional care and sophisticated environment where classic Porsche engines are restored. Visits are by appointment only, allowing clients to engage in detailed discussions about their specific needs and to tour the workshop. This personalised service underscores Tektronic’s commitment to building strong relationships with their clients and ensuring that their expectations are met or exceeded. Continuous innovation and expansion of services are central to Tektronic’s mission. The company is not only dedicated to maintaining high standards of quality and reliability but also looks forward to introducing future projects and services that will further enhance their restoration capabilities. This forward-thinking approach ensures that Tektronic remains at the forefront of the classic car restoration market, setting industry standards and making classic Porsche engine restoration accessible to a wider range of enthusiasts.

In conclusion, Tektronic is setting a new standard in the classic car restoration industry by offering Porsche owners a trusted and cost-effective alternative for engine restorations. The company’s dedication to preserving the performance and heritage of iconic Porsche models, combined with their meticulous attention to detail and commitment to quality, ensures that these vehicles continue to provide the driving experience they were designed for. Tektronic’s role in the classic car community is significant, as they provide services that are essential for the preservation of these historical vehicles. For more information, or to schedule a visit to their workshop, potential clients can contact Tektronic online or call 01786 625 624. Tektronic remains committed to innovation and excellence, continually striving to meet the evolving needs of classic Porsche enthusiasts across the UK.

Contact details

1. Company name: Tektronic Prestige Car Specialist

2. Website link: https://www.tektronic.co.uk/independent-porsche-specialist/classic-porsche-engine-rebuilds/

3. Contact email: [email protected]

4. Country: United Kingdom

5. City: Unit 1a, Alva Industrial Estate, Alva FK12 5DQ

6. Contact person name: Ewan Montgomer

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST